Novartis wins a key OK for Kymriah, but continuing manufacturing woes hobble rollout — rival Gilead CAR-T breaks into Europe

Novartis wins a key OK for Kymriah, but continuing manufacturing woes hobble rollout — rival Gilead CAR-T breaks into Europe

Submitted by admin on August 27, 2018 - 10:10am
Source: 
Endpoints
News Tags: 
Novartis
CAR-T
Kymriah
drug manufacturing
Headline: 
Novartis wins a key OK for Kymriah, but continuing manufacturing woes hobble rollout — rival Gilead CAR-T breaks into Europe
snippet: 

Novartis CAR-T manufacturing woes are continuing to put a crimp in its ability to provide therapy to all potential patients.

Do Not Allow Advertisers to Use My Personal information